NASDAQ:ALGN - Align Technology Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $411.23
  • Forecasted Upside: -13.57 %
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$475.80
▲ +2.11 (0.45%)
1 month | 3 months | 12 months
Get New Align Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALGN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$411.23
▼ -13.57% Downside Potential
This price target is based on 14 analysts offering 12 month price targets for Align Technology in the last 3 months. The average price target is $411.23, with a high forecast of $535.00 and a low forecast of $165.00. The average price target represents a -13.57% upside from the last price of $475.80.
Buy
The current consensus among 14 investment analysts is to buy stock in Align Technology. This rating has held steady since September 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2020Credit Suisse GroupBoost Price TargetOutperform$432.00 ➝ $515.00Medium
i
11/24/2020SVB LeerinkBoost Price TargetOutperform$460.00 ➝ $520.00Medium
i
11/24/2020The Goldman Sachs GroupBoost Price TargetBuy$472.00 ➝ $535.00Medium
i
11/24/2020Robert W. BairdBoost Price TargetOutperform$450.00 ➝ $530.00Medium
i
11/23/2020Piper SandlerBoost Price TargetOverweight$500.00 ➝ $525.00Medium
i
10/28/2020Stifel NicolausBoost Price TargetBuy$460.00 ➝ $515.00Low
i
10/22/2020Robert W. BairdBoost Price Target$370.00 ➝ $450.00High
i
10/22/2020Stifel NicolausBoost Price TargetBuy$360.00 ➝ $460.00High
i
10/22/2020BarclaysBoost Price TargetEqual Weight$300.00 ➝ $400.00High
i
10/22/2020Piper SandlerBoost Price TargetOverweight$400.00 ➝ $500.00High
i
10/22/2020Jefferies Financial GroupBoost Price TargetBuy$355.00 ➝ $450.00High
i
10/22/2020Credit Suisse GroupBoost Price TargetOutperform$348.00 ➝ $432.00High
i
10/22/2020SVB LeerinkBoost Price TargetOutperform$340.00 ➝ $460.00High
i
Rating by R. Newitter at SVB Leerink LLC
7/29/2020Berenberg BankDowngradeBuy ➝ Hold$306.00Low
i
7/23/2020BarclaysDowngradeOverweight ➝ Equal Weight$225.00 ➝ $300.00High
i
7/23/2020SVB LeerinkBoost Price TargetOutperform$310.00 ➝ $340.00High
i
Rating by R. Newitter at SVB Leerink LLC
7/23/2020Piper SandlerBoost Price TargetOverweight$258.00 ➝ $345.00High
i
7/20/2020Bank of AmericaDowngradeNeutral ➝ Underperform$280.00Low
i
7/14/2020SVB LeerinkBoost Price TargetOutperform$260.00 ➝ $310.00High
i
Rating by R. Newitter at SVB Leerink LLC
6/12/2020OTR GlobalUpgradePositiveLow
i
6/12/2020Stifel NicolausBoost Price TargetBuy$275.00 ➝ $300.00Low
i
5/22/2020Stifel NicolausBoost Price TargetBuy$230.00 ➝ $275.00High
i
5/1/2020UBS GroupLower Price TargetNeutral$270.00 ➝ $245.00Low
i
4/30/2020SVB LeerinkReiterated RatingOutperformLow
i
Rating by R. Newitter at SVB Leerink LLC
4/30/2020Credit Suisse GroupLower Price TargetOutperform$320.00 ➝ $275.00Low
i
4/30/2020Robert W. BairdBoost Price TargetOutperform$225.00 ➝ $248.00Low
i
Rating by Jeff Johnson at Robert W. Baird
4/30/2020Piper SandlerLower Price TargetOverweight$275.00 ➝ $258.00Low
i
3/19/2020StephensLower Price TargetEqual Weight$220.00 ➝ $165.00High
i
Rating by Chris Cooley at Stephens
3/13/2020Stifel NicolausLower Price TargetBuy$305.00 ➝ $275.00High
i
3/5/2020Robert W. BairdReiterated RatingBuy$325.00Medium
i
Rating by Jeff Johnson at Robert W. Baird
1/30/2020Piper SandlerBoost Price Target$240.00 ➝ $275.00Medium
i
1/28/2020UBS GroupBoost Price TargetNeutral$235.00 ➝ $280.00Medium
i
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$360.00Medium
i
11/19/2019StephensReiterated RatingHold$220.00Medium
i
Rating by Chris Cooley at Stephens
11/18/2019Stifel NicolausBoost Price TargetBuy$290.00 ➝ $305.00Medium
i
10/24/2019Bank of AmericaBoost Price TargetNeutral$220.00 ➝ $240.00High
i
10/7/2019BarclaysLower Price TargetOverweight$300.00 ➝ $272.00High
i
Rating by Steven Valiquette at Barclays PLC
10/7/2019GuggenheimDowngradeBuy ➝ Neutral$250.00 ➝ $200.00High
i
7/31/2019Piper Jaffray CompaniesSet Price TargetBuy$240.00N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
7/26/2019UBS GroupSet Price TargetHold$230.00Medium
i
Rating by Kevin Caliendo at UBS Group AG
7/26/2019Robert W. BairdLower Price TargetOutperform$336.00 ➝ $259.00Medium
i
7/25/2019Stifel NicolausLower Price TargetBuy$360.00 ➝ $290.00Low
i
7/25/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
i
7/25/2019Credit Suisse GroupLower Price TargetOutperform$340.00 ➝ $320.00High
i
7/25/2019Piper Jaffray CompaniesLower Price TargetOverweight$350.00 ➝ $240.00High
i
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformMedium
i
4/26/2019UBS GroupSet Price TargetHold$325.00Low
i
Rating by Kevin Caliendo at UBS Group AG
4/25/2019Credit Suisse GroupBoost Price TargetOutperform$305.00 ➝ $316.00High
i
4/25/2019BarclaysBoost Price TargetOverweight ➝ Overweight$335.00 ➝ $355.00Low
i
Rating by Steven Valiquette at Barclays PLC
4/25/2019Piper Jaffray CompaniesBoost Price TargetOverweight$300.00 ➝ $350.00Medium
i
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$335.00High
i
4/11/2019BarclaysSet Price TargetBuy$325.00Low
i
Rating by Steven Valiquette at Barclays PLC
3/25/2019Credit Suisse GroupBoost Price TargetOutperform$270.00 ➝ $278.00Low
i
3/19/2019Piper Jaffray CompaniesBoost Price TargetOverweight$250.00 ➝ $300.00Medium
i
3/14/2019OTR GlobalDowngradePositiveLow
i
3/5/2019Robert W. BairdBoost Price TargetOutperform ➝ Outperform$255.00 ➝ $286.00High
i
2/14/2019UBS GroupDowngradeBuy ➝ Neutral$275.00Low
i
1/30/2019Credit Suisse GroupLower Price TargetOutperform$277.00 ➝ $270.00High
i
1/30/2019SVB LeerinkLower Price TargetOutperform$300.00 ➝ $285.00High
i
1/17/2019UBS GroupInitiated CoverageBuy ➝ Buy$230.00High
i
1/6/2019BarclaysReiterated RatingBuy$275.00Medium
i
1/4/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$300.00 ➝ $210.00Low
i
1/2/2019Robert W. BairdLower Price TargetOutperform$330.00 ➝ $255.00High
i
11/20/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$375.00 ➝ $343.00High
i
11/19/2018William BlairReiterated RatingOutperformHigh
i
10/25/2018Morgan StanleyLower Price TargetEqual Weight$320.00 ➝ $300.00High
i
10/25/2018Credit Suisse GroupLower Price TargetOutperform$391.00 ➝ $375.00High
i
10/25/2018Robert W. BairdLower Price TargetOutperform$425.00 ➝ $330.00High
i
10/25/2018Stifel NicolausLower Price TargetAverage ➝ Buy$425.00 ➝ $346.00High
i
10/20/2018The Goldman Sachs GroupInitiated CoverageBuy$420.00Low
i
Rating by Nathan Rich at The Goldman Sachs Group, Inc.
10/9/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$315.00 ➝ $320.00Low
i
7/26/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$340.00 ➝ $391.00Medium
i
7/26/2018SVB LeerinkBoost Price TargetOutperform$400.00 ➝ $420.00Medium
i
7/26/2018BarclaysReiterated RatingBuyHigh
i
7/26/2018Robert W. BairdBoost Price TargetOutperform$351.00 ➝ $425.00High
i
7/26/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$375.00 ➝ $425.00High
i
7/20/2018Piper Jaffray CompaniesBoost Price TargetOverweight$425.00Low
i
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$290.00 ➝ $315.00Low
i
7/13/2018Stifel NicolausBoost Price TargetBuy$350.00 ➝ $375.00Low
i
6/26/2018Northcoast ResearchReiterated RatingBuy$430.00Low
i
6/25/2018Bank of AmericaInitiated CoverageBuy$420.00Low
i
6/21/2018BarclaysBoost Price TargetOverweight$410.00Medium
i
6/1/2018Stifel NicolausReiterated RatingBuy$320.00 ➝ $350.00Low
i
5/25/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $340.00Low
i
5/24/2018Piper Jaffray CompaniesBoost Price TargetOverweight ➝ Overweight$300.00 ➝ $325.00High
i
5/24/2018Jefferies Financial GroupBoost Price TargetBuy$350.00High
i
5/24/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$305.00 ➝ $360.00High
i
5/22/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$320.00 ➝ $350.00Medium
i
5/21/2018BarclaysBoost Price TargetOverweight ➝ Overweight$295.00 ➝ $325.00Medium
i
5/16/2018Evercore ISIInitiated CoverageOutperform$340.00Low
i
4/26/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $300.00High
i
4/26/2018BarclaysBoost Price TargetOverweight ➝ Overweight$290.00 ➝ $295.00High
i
4/26/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$270.00 ➝ $290.00Low
i
4/26/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$295.00 ➝ $320.00Medium
i
4/20/2018Berenberg BankInitiated CoverageBuy$305.00High
i
4/19/2018Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$220.00High
i
4/18/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$300.00 ➝ $270.00High
i
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$290.00Medium
i
1/31/2018Piper Jaffray CompaniesReiterated RatingBuy$300.00High
i
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $305.00Medium
i
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$276.00 ➝ $290.00Medium
i
1/30/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$265.00 ➝ $295.00High
i
1/19/2018StephensDowngradeOverweight ➝ Equal Weight$230.00Low
i
1/4/2018Credit Suisse GroupUpgradeBuy$276.00High
i
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$250.00Low
i
11/29/2017Robert W. BairdReiterated RatingBuy$290.00Medium
i
Rating by Jeff Johnson at Robert W. Baird
11/28/2017Credit Suisse GroupReiterated RatingOutperform$261.00 ➝ $276.00Low
i
11/27/2017Morgan StanleyBoost Price TargetOverweight$257.00 ➝ $300.00High
i
11/21/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$245.00 ➝ $265.00N/A
i
11/9/2017Credit Suisse GroupReiterated RatingOutperform ➝ Positive$209.00 ➝ $261.00N/A
i
10/27/2017Credit Suisse GroupBoost Price TargetOutperform$175.00 ➝ $209.00N/A
i
10/27/2017SVB LeerinkReiterated RatingOutperform$250.00N/A
i
10/27/2017Robert W. BairdReiterated RatingBuy$245.00N/A
i
Rating by Jeff Johnson at Robert W. Baird
10/23/2017Stifel NicolausBoost Price TargetBuy$205.00 ➝ $225.00N/A
i
10/19/2017Stifel NicolausReiterated RatingBuy ➝ Buy$205.00 ➝ $225.00N/A
i
10/18/2017Robert W. BairdSet Price TargetBuy$208.00N/A
i
Rating by Jeff Johnson at Robert W. Baird
10/10/2017Northcoast ResearchReiterated RatingBuy$200.00 ➝ $230.00N/A
i
10/6/2017Morgan StanleyReiterated RatingOverweight$195.00 ➝ $220.00N/A
i
9/15/2017The Goldman Sachs GroupBoost Price TargetBuy$185.00 ➝ $210.00Low
i
9/12/2017Robert W. BairdReiterated RatingBuyMedium
i
9/11/2017Piper Jaffray CompaniesReiterated RatingBuy$200.00Medium
i
8/7/2017Stifel NicolausReiterated RatingBuy$200.00 ➝ $205.00Low
i
7/28/2017SVB LeerinkReiterated RatingOutperform$194.00 ➝ $199.00Low
i
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$176.00High
i
7/28/2017Bank of AmericaUpgradeNeutral ➝ Buy$175.00 ➝ $193.00High
i
7/17/2017Morgan StanleyReiterated RatingOverweight$175.00 ➝ $182.00Low
i
7/13/2017Credit Suisse GroupReiterated RatingOutperform$140.00 ➝ $170.00Low
i
6/26/2017SVB LeerinkBoost Price TargetOutperform$149.00 ➝ $194.00Low
i
6/23/2017Stifel NicolausReiterated RatingMarket Perform ➝ Buy$145.00 ➝ $200.00High
i
6/21/2017Northcoast ResearchReiterated RatingBuy$164.00 ➝ $186.00Low
i
6/19/2017Morgan StanleyReiterated RatingOverweight$175.00High
i
6/1/2017Jefferies Financial GroupReiterated RatingBuy$150.00Low
i
4/29/2017SVB LeerinkReiterated RatingOutperform$118.00 ➝ $149.00Low
i
4/29/2017Jefferies Financial GroupReiterated RatingBuy$110.00 ➝ $150.00Low
i
4/28/2017Robert W. BairdUpgradeNeutral ➝ Outperform$105.00 ➝ $155.00High
i
4/11/2017Stifel NicolausReiterated RatingBuy$130.00Low
i
1/23/2017Jefferies Financial GroupBoost Price TargetBuy$105.00 ➝ $110.00N/A
i
11/28/2016Stifel NicolausBoost Price TargetBuy$95.00 ➝ $110.00N/A
i
11/8/2016Jefferies Financial GroupReiterated RatingBuy$100.00 ➝ $105.00N/A
i
10/19/2016Morgan StanleySet Price TargetBuy$114.00N/A
i
Rating by Steve Beuchaw at Morgan Stanley
10/3/2016Robert W. BairdDowngradeOutperform ➝ Neutral$96.00N/A
i
Rating by Jeff Johnson at Robert W. Baird
7/28/2016Stifel NicolausBoost Price TargetBuy$82.00 ➝ $95.00N/A
i
6/4/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Robert Willoughby at Credit Suisse Group AG
6/4/2016Robert W. BairdReiterated RatingBuyN/A
i
Rating by Jeff Johnson at Robert W. Baird
6/4/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Richard Newitter at SVB Leerink LLC
5/17/2016Piper Jaffray CompaniesReiterated RatingOverweight$74.00 ➝ $82.00N/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
5/14/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Steve Beuchaw at Morgan Stanley
5/11/2016Credit Suisse GroupInitiated CoverageOutperform$84.00N/A
i
4/29/2016Morgan StanleyReiterated RatingBuy$84.00N/A
i
4/29/2016Jefferies Financial GroupReiterated RatingBuy$85.00N/A
i
3/24/2016Canaccord GenuityReiterated RatingBuy$72.00 ➝ $80.00N/A
i
3/23/2016Roth CapitalBoost Price TargetBuy$72.00 ➝ $80.00N/A
i
Rating by Chris Lewis at Roth Capital
3/8/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by Matthew O'Brien at Piper Jaffray Companies
1/29/2016Roth CapitalReiterated RatingBuyN/A
i
Rating by Chris Lewis at Roth Capital
1/29/2016William BlairReiterated RatingBuyN/A
i
Rating by John Kreger at William Blair
1/29/2016Robert W. BairdBoost Price TargetOutperform$72.00 ➝ $74.00N/A
i
1/29/2016SVB LeerinkReiterated RatingOutperform$75.00 ➝ $81.00N/A
i
Rating by Richard Newitter at SVB Leerink LLC
1/29/2016Jefferies Financial GroupBoost Price TargetBuy$72.00 ➝ $75.00N/A
i
1/29/2016The Goldman Sachs GroupBoost Price TargetBuy$67.00 ➝ $72.00N/A
i
1/29/2016Stifel NicolausBoost Price TargetBuy$80.00 ➝ $82.00N/A
i
1/20/2016Roth CapitalReiterated RatingBuyN/A
i
Rating by Chris Lewis at Roth Capital
(Data available from 11/27/2015 forward)
Align Technology logo
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $475.80
$468.24
$477.85

50 Day Range

MA: $420.51
$323.62
$491.91

52 Week Range

Now: $475.80
$127.88
$507.05

Volume

5,009 shs

Average Volume

705,884 shs

Market Capitalization

$37.52 billion

P/E Ratio

21.65

Dividend Yield

N/A

Beta

1.75